Brewer Science Acquires Heraeus Epurio’s Semiconductor Chemicals Business
AI-summarised brief · reviewed before publication
Brewer Science, Inc. completed the acquisition of Heraeus Epurio’s semiconductor chemicals business, adding the Dayton, Ohio production facility and its Asia‑based sales and technical teams to its portfolio. The deal brings in-formulation capabilities for ultrapure photoacid generators, photoinitiators, monomers and crosslinkers, chemicals that must meet sub‑ppm trace‑metal tolerances for the most advanced chip nodes. Brewer’s “Zero Defects” quality program will now extend across synthesis, formulation and manufacturing, creating a fully integrated supply chain. Company co‑CEOs Dr. Sri Kommu and Dan Brewer said the move deepens Brewer’s 45‑year materials‑science legacy and positions it to anticipate future node requirements. The acquisition also expands U.S. advanced‑manufacturing capacity, complementing recent investments in Arizona and Missouri.
💡 Why It Matters
- · By internalizing ultra‑pure chemical production, Brewer can guarantee defect‑free supply for next‑generation chips, a critical advantage as node dimensions shrink and tolerances tighten.
- · This vertical integration reshapes the domestic supply chain, reducing reliance on overseas sources for the most contamination‑sensitive materials.